White House launches direct-to-consumer drug site TrumpRx. Here's what to know
Summary
The CNBC article reports that the White House launched TrumpRx, a direct-to-consumer hub linking consumers to pharma discounts rather than selling drugs. It highlights potential savings for cash-paying customers, questions whether insured patients gain, and notes discounts on GLP-1 meds from Lilly and Novo Nordisk with deals expected to expand; analysts warn that insurer prices and rebates may limit overall consumer benefit.